Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Cash from Operations (2016 - 2025)

Historic Cash from Operations for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $26.7 million.

  • AtriCure's Cash from Operations rose 3355.33% to $26.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.1 million, marking a year-over-year increase of 31491.63%. This contributed to the annual value of $12.2 million for FY2024, which is 17216.77% up from last year.
  • According to the latest figures from Q3 2025, AtriCure's Cash from Operations is $26.7 million, which was up 3355.33% from $21.6 million recorded in Q2 2025.
  • AtriCure's 5-year Cash from Operations high stood at $26.7 million for Q3 2025, and its period low was -$24.6 million during Q1 2022.
  • For the 5-year period, AtriCure's Cash from Operations averaged around $951263.2, with its median value being $301000.0 (2021).
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 66896.55% in 2022, then skyrocketed by 866086.96% in 2023.
  • AtriCure's Cash from Operations (Quarter) stood at $301000.0 in 2021, then plummeted by 84.72% to $46000.0 in 2022, then soared by 8660.87% to $4.0 million in 2023, then skyrocketed by 44.81% to $5.8 million in 2024, then skyrocketed by 357.78% to $26.7 million in 2025.
  • Its Cash from Operations was $26.7 million in Q3 2025, compared to $21.6 million in Q2 2025 and -$11.0 million in Q1 2025.